Rare disease | Australian Biotech Company News

Home Tags Rare disease

Biotechnology

Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU

BioChannel - May 19, 2020

Biotechnology

Phase III Failure Sinks Drug for Rare Neurological Disorder

BioChannel - May 8, 2020

Biotechnology

Update: FDA Imposes No Penalties for Novartis Data Manipulation Scandal

BioChannel - April 2, 2020

Biotechnology

Ipsen Resumes Phase III Testing for Rare Disease Drug and Abandons...

BioChannel - March 31, 2020

Biotechnology

First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M

BioChannel - February 10, 2020

Biotechnology

Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III

BioChannel - November 26, 2019

Biotechnology

€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics

BioChannel - November 7, 2019

Biotechnology

FDA Considers Imposing Penalties on Novartis over Data Manipulation

BioChannel - August 7, 2019

Biotechnology

This Biotech Treats a Neurological Autoimmune Disorder Using DNA

BioChannel - May 31, 2019

Biotechnology

Update: Novartis’ Neurological Gene Therapy Receives FDA Approval

BioChannel - May 24, 2019

12 Page 1 of 2

Stay connected

Recent posts

Genexine and NeoImmuneTech (NIT) – GX-I7 [also called NT-17 or Hyleukin-7™ (rhIL-7-hyFc)]

BioChannel - July 9, 2020

Trust me if you can

BioChannel - July 9, 2020

China Pursuing ‘Aggressive’ Biotechnology Strategy – National Defense Magazine

BioChannel - July 9, 2020

Random article

Genexine and NeoImmuneTech (NIT) – GX-I7 [also called NT-17 or Hyleukin-7™...

Trust me if you can

China Pursuing ‘Aggressive’ Biotechnology Strategy – National Defense Magazine

NIH establishes a unified clinical trial network for testing COVID-19 vaccines